INOVAIT launches Canada-wide medtech job board to connect talent with innovation

Jun 2, 2025

INOVAIT, the Canadian image-guided therapy (IGT) and AI network, is pleased to announce the launch of the network’s job board—a curated platform showcasing job opportunities from across Canada’s exciting medtech sector.

Developed in response to increasing demand from our members and job seekers, the INOVAIT Network Job Board offers job seekers direct access to high-impact roles at some of the country’s top companies working in emerging medical technologies. Updated daily, the platform features listings from across the INOVAIT network and is designed to help talented professionals launch or advance their careers in a home-grown company right here in Canada.

Job seekers can browse postings and filter by job function, seniority, company size, stage, location, and work arrangements such as remote and hybrid work. Candidates can also join the INOVAIT Talent Network, which uses resume-matching technology to automatically connect qualified candidates with relevant opportunities. When there’s a strong match, the platform can directly introduce the candidate to the hiring company to accelerate the recruitment process. Users may also set job alerts to stay informed when new roles matching their interests become available.

 “As our industry members scale, they create high-quality jobs for Canadians and need access to top-tier talent from across our country,” says Raphael Ronen, co-executive director of INOVAIT. “This job board is designed to help bridge that gap—connecting exceptional individuals with companies driving innovation in medtech and artificial intelligence.”

 “The INOVAIT Network Job Board is a great initiative that will bring value to the medtech community,” said Dr. Saumik Biswas, CEO & co-founder of Tenomix, an INOVAIT member company. “At Tenomix, we’re thrilled to see this kind of support for innovative Canadian companies and talented professionals, and we’re grateful to be part of a network that continues to invest in meaningful tools for growth.”

“Artificial intelligence offers some of the most exciting and socially beneficial applications in image-guided therapy,” said the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions. “INOVAIT’s newest initiative will expedite connections between Canada’s brightest talent and our leading-edge IGT companies to successfully scale AI applications and transform healthcare globally.”

Share this on social media

Learn more about the network

Cohesic flips the script on incorporating AI into healthcare

Cohesic flips the script on incorporating AI into healthcare

Jordan Engbers, Chief Science Officer of Cohesic, a data scientist who spent years in clinical research, is painfully aware of the chasm between the promise and reality of AI in healthcare. While an AI model might work within a study where researchers systematically gather, clean up, and standardize the data, real-world healthcare data is often too messy and unreliable to use for clinical decisions.

Seeing beneath the surface: How MIMOSA is transforming wound care

Seeing beneath the surface: How MIMOSA is transforming wound care

Dr. Karen Cross, a plastic and reconstructive surgeon and CEO of MIMOSA Diagnostics, saw countless patients with diabetes and chronic wounds in her clinic. People with diabetes have an increased risk of developing pressure wounds due to complications like poor circulation and nerve damage. Many of her patients came into her clinic too late to prevent complications and ultimately had lower extremity amputations to prevent fatal infections.

INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care

INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care

Industry members in the INOVAIT Network are developing AI technologies that are revolutionizing the diagnosis and treatment of disease and improving patient outcomes while building the Canadian healthcare economy. The health data these companies need to create their technologies most often reside with Canadian healthcare institutions that are reluctant to share data with commercial partners due to caution stemming from a lack of clarity in privacy legislation and historical practices focused primarily on minimizing privacy and security risks.